We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.7B
AUM Growth
-$178M
Cap. Flow
-$1.14B
Cap. Flow %
-8.27%
Top 10 Hldgs %
25.57%
Holding
3,040
New
254
Increased
776
Reduced
1,044
Closed
100

Sector Composition

Rank Sector Weight
1 Technology 26.03%
2 Healthcare 12.56%
3 Financials 11.14%
4 Consumer Discretionary 11.02%
5 Industrials 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORIC icon
2401
Oric Pharmaceuticals
ORIC
$1.42B
$161K ﹤0.01%
+20,737
New +$118K
MCBS icon
2402
MetroCity Bankshares
MCBS
$1.05B
$161K ﹤0.01%
8,982
ENFN
2403
DELISTED
Enfusion, Inc.
ENFN
$159K ﹤0.01%
14,206
MOFG
2404
DELISTED
MidWestOne Financial Group
MOFG
$159K ﹤0.01%
7,454
TWOU
2405
DELISTED
2U Inc
TWOU
$159K ﹤0.01%
1,316
SMMT icon
2406
Summit Therapeutics
SMMT
$11.2B
$159K ﹤0.01%
+63,318
New +$116K
CMPX icon
2407
Compass Therapeutics
CMPX
$407M
$159K ﹤0.01%
+49,953
New +$157K
ASRT
2408
DELISTED
Assertio
ASRT
$159K ﹤0.01%
+1,951
New +$181K
WTBA icon
2409
West Bancorporation
WTBA
$511M
$157K ﹤0.01%
8,547
BV icon
2410
BrightView Holdings
BV
$1.08B
$157K ﹤0.01%
21,908
+6,163
+39% +$38.9K
GCO icon
2411
Genesco
GCO
$394M
$157K ﹤0.01%
6,271
SCPH
2412
DELISTED
scPharmaceuticals
SCPH
$156K ﹤0.01%
+15,323
New +$160K
FORR icon
2413
Forrester Research
FORR
$224M
$156K ﹤0.01%
5,365
STOK icon
2414
Stoke Therapeutics
STOK
$2.02B
$155K ﹤0.01%
14,616
+2,995
+26% +$31.9K
AESI icon
2415
Atlas Energy Solutions
AESI
$1.47B
$155K ﹤0.01%
+8,941
New +$156K
LUNA
2416
DELISTED
Luna Innovations Incorporated
LUNA
$155K ﹤0.01%
+16,999
New +$135K
ASTS icon
2417
AST SpaceMobile
ASTS
$21.4B
$155K ﹤0.01%
+32,937
New +$171K
HIFS icon
2418
Hingham Institution for Saving
HIFS
$686M
$155K ﹤0.01%
726
RM icon
2419
Regional Management Corp
RM
$301M
$155K ﹤0.01%
5,066
NETI
2420
DELISTED
Eneti Inc.
NETI
$154K ﹤0.01%
12,718
ODC icon
2421
Oil-Dri
ODC
$1.27B
$154K ﹤0.01%
+5,218
New +$115K
ALLK
2422
DELISTED
Allakos
ALLK
$154K ﹤0.01%
+35,276
New +$159K
Z icon
2423
Zillow
Z
$8.08B
$154K ﹤0.01%
3,059
-593
-16% -$27.3K
MRSN
2424
DELISTED
Mersana Therapeutics
MRSN
$153K ﹤0.01%
1,866
GTLB icon
2425
GitLab
GTLB
$7.32B
$153K ﹤0.01%
+3,001
New +$112K

Similar funds

MetLife Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, MetLife Investment Management held 3,040 positions worth $13.7B, down 1.3% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

MetLife Investment Management withdrew a net $1.14B in Q2 2023, closing 100 positions and reducing 1,044 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $3.05M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Knife River worth $2.46M.

  • MetLife Investment Management's largest Q2 2023 buy was Knife River: 56,478 shares worth $2.46M.
  • MetLife Investment Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $14.9M increase.
  • MetLife Investment Management's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $901M.
  • MetLife Investment Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $3.05M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $13.7B portfolio in Q2 2023.
  • MetLife Investment Management opened 254 new positions and closed 100 in Q2 2023.
  • MetLife Investment Management's portfolio value fell 1.3% quarter-over-quarter to $13.7B.

Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.